For: | Johnson SK, Haun RS. Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth. World J Gastroenterol 2009; 15(27): 3355-3366 [PMID: 19610136 DOI: 10.3748/wjg.15.3355] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i27/3355.htm |
Number | Citing Articles |
1 |
Jia Qing Shen, Jie Shen, Xing Peng Wang. Expression of insulin-like growth factor binding protein-4 (IGFBP-4) in acute pancreatitis induced by l-arginine in mice. Acta Histochemica 2012; 114(4): 379 doi: 10.1016/j.acthis.2011.07.008
|
2 |
Xin-yu Huang, Hong-cheng Wang, Zhou Yuan, Ang Li, Mei-lan He, Kai-xing Ai, Qi Zheng, Huan-long Qin. Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells. Acta Pharmacologica Sinica 2010; 31(6): 741 doi: 10.1038/aps.2010.54
|
3 |
Yuanhui Jia, Ting Li, Xiaojie Huang, Xianghong Xu, Xinyao Zhou, Linyan Jia, Jingping Zhu, Dandan Xie, Kai Wang, Qian Zhou, Liping Jin, Jiqin Zhang, Tao Duan. Dysregulated DNA Methyltransferase 3A Upregulates IGFBP5 to Suppress Trophoblast Cell Migration and Invasion in Preeclampsia. Hypertension 2017; 69(2): 356 doi: 10.1161/HYPERTENSIONAHA.116.08483
|
4 |
Yuejun Wang, Zhi Jia, Shu Diao, Xiao Lin, Xiaomeng Lian, Liping Wang, Rui Dong, Dayong Liu, Zhipeng Fan. IGFBP5 enhances osteogenic differentiation potential of periodontal ligament stem cells and Wharton's jelly umbilical cord stem cells, via the JNK and MEK/Erk signalling pathways. Cell Proliferation 2016; 49(5): 618 doi: 10.1111/cpr.12284
|
5 |
Chengyuan Dong, Junwen Zhang, Sheng Fang, Fusheng Liu. IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells. Cell Division 2020; 15(1) doi: 10.1186/s13008-020-00061-6
|
6 |
Saúl Álvarez-Teijeiro, Cristina García-Inclán, M. Villaronga, Pedro Casado, Francisco Hermida-Prado, Rocío Granda-Díaz, Juan Rodrigo, Fernando Calvo, Nagore del-Río-Ibisate, Alberto Gandarillas, Francisco Morís, Mario Hermsen, Pedro Cutillas, Juana García-Pedrero. Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets. Cancers 2018; 10(9): 334 doi: 10.3390/cancers10090334
|
7 |
Chen Sun, Ann H. Rosendahl, Roland Andersson, DeQuan Wu, Xiangdong Wang. The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer. Pancreatology 2011; 11(2): 252 doi: 10.1159/000327715
|
8 |
Jennifer A. Waters, Ixchel Urbano, Mikella Robinson, Carrie D. House. Insulin-like growth factor binding protein 5: Diverse roles in cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1052457
|
9 |
Weiwei Lin, Rui Niu, Seong-Min Park, Yan Zou, Sung Soo Kim, Xue Xia, Songge Xing, Qingshan Yang, Xinhong Sun, Zheng Yuan, Shuchang Zhou, Dongya Zhang, Hyung Joon Kwon, Saewhan Park, Chan Il Kim, Harim Koo, Yang Liu, Haigang Wu, Meng Zheng, Heon Yoo, Bingyang Shi, Jong Bae Park, Jinlong Yin. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-37306-1
|
10 |
A. Vijayan, D. Guha, F. Ameer, I. Kaziri, C.C. Mooney, L. Bennett, A. Sureshbabu, E. Tonner, J. Beattie, G.J. Allan, J. Edwards, D.J. Flint. IGFBP-5 enhances epithelial cell adhesion and protects epithelial cells from TGFβ1-induced mesenchymal invasion. The International Journal of Biochemistry & Cell Biology 2013; 45(12): 2774 doi: 10.1016/j.biocel.2013.10.001
|
11 |
William P. Marinello, Zahra S. Mohseni, Sarah J. Cunningham, Christine Crute, Rong Huang, Jun J. Zhang, Liping Feng. Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes. The FASEB Journal 2020; 34(11): 14182 doi: 10.1096/fj.202000716RR
|
12 |
Junyun Wang, Nan Ding, Yongjun Li, Hua Cheng, Dong Wang, Qiong Yang, Youhui Deng, Yaran Yang, Yanming Li, Xiuyan Ruan, Fang Xie, Hua Zhao, Xiangdong Fang. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells. Oncotarget 2015; 6(24): 20636 doi: 10.18632/oncotarget.4114
|
13 |
Aleksandar Sokolović, Milka Sokolović, Willem Boers, Ronald PJ Oude Elferink, Piter J Bosma. Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells. Fibrogenesis & Tissue Repair 2010; 3(1) doi: 10.1186/1755-1536-3-3
|
14 |
Gökçe Güllü, Irem Peker, Aptullah Haholu, Fatih Eren, Zafer Küçükodaci, Bülent Güleç, Hüseyin Baloglu, Can Erzik, Ayse Özer, Mustafa Akkiprik. Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5. Genetics and Molecular Biology 2015; 38(1): 21 doi: 10.1590/S1415-475738120140167
|
15 |
Beiying Zhang, Xiaoling Deng, Ruolan You, Jingru Liu, Diyu Hou, Xiaoting Wang, Shucheng Chen, Dongliang Li, Qiang Fu, Jingdong Zhang, Huifang Huang, Xiaoli Chen. Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia. Neoplasia 2024; 47: 100952 doi: 10.1016/j.neo.2023.100952
|
16 |
Cunming Duan, John B. Allard. Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00100
|
17 |
Mustafa Akkiprik, İrem Peker, Tolga Özmen, Gökçe Amuran, Bahadır Güllüoğlu, Handan Kaya, Ayşe Özer. Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments. Genes 2015; 6(4): 1201 doi: 10.3390/genes6041201
|
18 |
Younghay Lee, Sun-Hye Shin, Kyung-Ah Cho, Yu-Hee Kim, So-Youn Woo, Han Su Kim, Sung-Chul Jung, Inho Jo, Hee-Sook Jun, Woo-Jae Park, Joo-Won Park, Kyung-Ha Ryu. Administration of Tonsil-Derived Mesenchymal Stem Cells Improves Glucose Tolerance in High Fat Diet-Induced Diabetic Mice via Insulin-Like Growth Factor-Binding Protein 5-Mediated Endoplasmic Reticulum Stress Modulation. Cells 2019; 8(4): 368 doi: 10.3390/cells8040368
|
19 |
X. J. Wang, J. J. Shi, J. F. Yang, Y. Liang, Y. F. Wang, M. L. Wu, S. Y. Li, X. D. Guo, Z. G. Wang, D. J. Liu. Molecular Characterization and Expression Pattern of Gene IGFBP-5 in the Cashmere Goat (Capra hircus). Asian-Australasian Journal of Animal Sciences 2012; 25(5): 606 doi: 10.5713/ajas.2011.11290
|
20 |
David T. Ting, Ben S. Wittner, Matteo Ligorio, Nicole Vincent Jordan, Ajay M. Shah, David T. Miyamoto, Nicola Aceto, Francesca Bersani, Brian W. Brannigan, Kristina Xega, Jordan C. Ciciliano, Huili Zhu, Olivia C. MacKenzie, Julie Trautwein, Kshitij S. Arora, Mohammad Shahid, Haley L. Ellis, Na Qu, Nabeel Bardeesy, Miguel N. Rivera, Vikram Deshpande, Cristina R. Ferrone, Ravi Kapur, Sridhar Ramaswamy, Toshi Shioda, Mehmet Toner, Shyamala Maheswaran, Daniel A. Haber. Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells. Cell Reports 2014; 8(6): 1905 doi: 10.1016/j.celrep.2014.08.029
|
21 |
Xiaoqun Dong, Milind Javle, Kenneth R. Hess, Rachna Shroff, James L. Abbruzzese, Donghui Li. Insulin-Like Growth Factor Axis Gene Polymorphisms and Clinical Outcomes in Pancreatic Cancer. Gastroenterology 2010; 139(2): 464 doi: 10.1053/j.gastro.2010.04.042
|
22 |
Varsha P. Brahmkhatri, Chinmayi Prasanna, Hanudatta S. Atreya. Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/538019
|
23 |
Jiangong Niu, Yu‐Jing Huang, Sheng Wei, Zhensheng Liu, Li‐E Wang, Shine Chang, Robert M. Chamberlain, Adel K. El‐Naggar, Erich M. Sturgis, Qingyi Wei. Association between a functional polymorphism (‐1195T>C) in the IGFBP5 promoter and head and neck cancer risk. Head & Neck 2011; 33(5): 650 doi: 10.1002/hed.21514
|
24 |
Robert C. Baxter. IGF binding proteins in cancer: mechanistic and clinical insights. Nature Reviews Cancer 2014; 14(5): 329 doi: 10.1038/nrc3720
|
25 |
Z. M. Zhang, L. Min, D. L. Jiang, Z. Y. Han, Lihua Wang. Insulin-Like Growth Factor Binding Protein 5: an Important Regulator of Early Osteogenic Differentiation of hMSCs. Folia Biologica 2021; 67(3): 118 doi: 10.14712/fb2021067030118
|